Related Experiment Video
Updated: Apr 15, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
General issues on microbial translocation in HIV-infected patients
1Department of Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. raffaele.bruno@unipv.it.
Abstract:
The lumen of the gastrointestinal tract is home to an enormous quantity of different bacterial species that thrive in an often symbiotic relationship with the host. It is the principal source of microbial products because of its massive bacterial load. Injury to the immune component of the gastrointestinal mucosal surface, along with damage to the intestinal epithelial microenvironment with its antimicrobial functions, may affect systemic immune activation during the chronic phase of HIV infection through the increased translocation of luminal microbial products. Moreover, microbial translocation, which is defined as "the passage of both viable and nonviable microbes and microbial products such as endotoxin across anatomically intact intestinal barrier", may be a fundamental mechanism through which HIV accelerates progression of chronic viral hepatitis. Improvements in the tools available to microbiota research, and especially advancement of our knowledge in this area may help us in controlling the evolution of HIV disease, although population complexity and diversity between individuals make this challenging.
Insights
Gut microbiota products can increase HIV disease progression and chronic viral hepatitis. Understanding microbial translocation is key to managing these conditions, despite individual variations.
Area of Science:
- Gastroenterology
- Immunology
- Microbiology
Background:
- The gastrointestinal tract harbors a vast number of bacteria, serving as a major source of microbial products.
- Damage to the gut's immune and epithelial components can lead to increased translocation of these products.
Purpose of the Study:
- To explore the role of microbial translocation in HIV infection and chronic viral hepatitis.
- To investigate how gut barrier integrity impacts systemic immune activation in HIV.
Main Methods:
- The study defines microbial translocation as the passage of microbes and microbial products across the intestinal barrier.
- It reviews the impact of gut microbiota on immune responses during chronic HIV infection.
Main Results:
- Increased translocation of luminal microbial products can affect systemic immune activation in chronic HIV.
- Microbial translocation may be a key factor accelerating the progression of chronic viral hepatitis in HIV patients.
Conclusions:
- Advancements in microbiota research may aid in controlling HIV disease progression.
- The complexity and individual diversity of the gut microbiota present challenges in managing HIV and associated conditions.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Sexually Transmitted Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cytomegalovirus Disease

